Cover Story
By Matthew Bin Han Ong
Summer of 2020 was supposed to be a brief period of respite between Wave 1 and Wave 2 of COVID-19, but out of sheer stubbornness, for reasons political, or both, SARS-CoV-2 didn't get the message.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- How the 2024 elections can impact cancer policy
- University of Hawai‘i Cancer Center receives NCI designation with “outstanding” score
- NCI’s myeloMATCH will use biomarkers to match patients with myeloid cancer to trials
- New exhibit: Presidential elections and tobacco